Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study

Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study

Excessive activation of the mineralocorticoid receptor (MR) underlies the pathophysiology of heart failure and chronic kidney disease. Hyperkalemia risk limits the therapeutic use of conventional MR antagonists. AZD9977 is a nonsteroidal, selective MR modulator that may protect nonepithelial tissues...

Full description

Bibliographic Details
Main Authors:	Andrew Whittaker, Åsa M. Kragh, Judith Hartleib‐Geschwindner, Muna Albayaty, Anna Backlund, Peter J. Greasley, Maria Heijer, Magnus Kjaer, Pablo Forte, Robert Unwin, Linda Wernevik, Hans Ericsson
Format:	Article
Language:	English
Published:	Wiley 2020-03-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.12705

Similar Items

The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone
by: Krister Bamberg, et al.
Published: (2019-02-01)

Preclinical pharmacology of AZD9977: A novel mineralocorticoid receptor modulator separating organ protection from effects on electrolyte excretion.
by: Krister Bamberg, et al.
Published: (2018-01-01)

Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies
by: Victor Balaguer, et al.
Published: (2020-09-01)

Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology bronchodilator
by: Eulalia Jimenez, et al.
Published: (2020-09-01)

Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction
by: Karin Nelander, et al.
Published: (2021-05-01)

Some observations on the activities of mineralocorticoids and mineralocorticoid antagonists
by: Huston, G. J.
Published: (1979)

Safety, pharmacokinetics and pharmacodynamics of the selective glucocorticoid receptor modulator AZD7594, following inhalation in healthy Japanese volunteers
by: Prothon S, et al.
Published: (2019-11-01)

Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
by: Bjermer L, et al.
Published: (2015-02-01)

Mineralocorticoid hypertension
by: Vishal Gupta
Published: (2011-01-01)

Synergistic effects of combining PARP inhibitor (AZD2281) and ATR inhibitor (AZD6738) in Ewing Sarcoma cell lines
by: Meyer, Stephanie C.
Published: (2018)

Mineralocorticoid Receptor Antagonists
by: Ilaria Spoletini, et al.
Published: (2019-01-01)

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
by: Sheng L, et al.
Published: (2021-03-01)

AZD9291-induced Acute Interstitial Lung Disease
by: Ke-Ke Nie, et al.
Published: (2016-01-01)

Mineralocorticoid receptor blockade for renoprotection
by: Dae Ryong Cha
Published: (2018-09-01)

Evaluation of AZD1446 as a Therapeutic in DYT1 Dystonia
by: Chelsea N. Zimmerman, et al.
Published: (2017-06-01)

Aldosterone-Mineralocorticoid Receptor Cell Biology to Translational Medicine
Published: (2019)

Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
by: Gurudatt Chandorkar, et al.
Published: (2017-03-01)

Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects
by: Hwang S, et al.
Published: (2021-06-01)

A Sensitive and Robust Ultra HPLC Assay with Tandem Mass Spectrometric Detection for the Quantitation of the PARP Inhibitor Olaparib (AZD2281) in Human Plasma for Pharmacokinetic Application
by: Jeffrey Roth, et al.
Published: (2014-06-01)

Localization of mineralocorticoid receptors at mammalian synapses.
by: Eric M Prager, et al.
Published: (2010-01-01)

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
by: John W. Funder
Published: (2017-05-01)

Mineralocorticoid hypertension and hypokalaemia induced by posaconazole
by: Charlotte Boughton, et al.
Published: (2018-02-01)

AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo
by: Gang Shen, et al.
Published: (2018-10-01)

A case report of toxic epidermal necrolysis associated with AZD-9291
by: Wang J, et al.
Published: (2018-07-01)

Determination and Occurrence of Mineralocorticoids in Taihu Lake of China
by: Li Zhao, et al.
Published: (2021-08-01)

Pathophysiological Roles of Aldosterone and Mineralocorticoid Receptor in the Kidney
by: Kazi Rafiq, et al.
Published: (2011-01-01)

Familial Mineralocorticoid Induced Hypertension in the Sultanate of Oman
by: Nicholas JY Woodhouse, et al.
Published: (2008-07-01)

Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging
by: Stefania Gorini, et al.
Published: (2019-08-01)

ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor
by: Shigeru Shibata, et al.
Published: (2018-07-01)

Mineralocorticoid receptors in the pathophysiology of vascular inflammation and atherosclerosis.
by: Mary Elizabeth Moss, et al.
Published: (2015-09-01)

The Role of Mineralocorticoid Receptor Signaling in Genitourinary Cancers
by: Yujiro Nagata, et al.
Published: (2019-02-01)

Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology
by: Lisa M. Sevilla, et al.
Published: (2018-06-01)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
by: N. Muñoz-Durango, et al.
Published: (2015-01-01)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021-06-01)

Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging
by: Yekatarina Gadasheva, et al.
Published: (2021-05-01)

Borbón, J. A. (2012), América Latina: caminos de la integración regional, FLACSO, Costa Rica/San José, 175p., ISBN 978-9977-68-240-2
by: Vitor Helio Pererira de Souza
Published: (2015-08-01)

Borbón, J. A. (2012), América Latina: caminos de la integración regional , FLACSO , Costa Rica/San José, 175p., ISBN 978-9977-68-240-2
by: Vitor Helio Pererira de Souza
Published: (2015-01-01)

Tracing Nutrient Flux Following Monocarboxylate Transporter-1 Inhibition with AZD3965
by: Marta Braga, et al.
Published: (2020-06-01)

Mathematical modeling of ER-positive breast cancer treatment with AZD9496 and palbociclib
by: Hsiu-Chuan Wei
Published: (2020-04-01)

The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial
by: Patel NR, et al.
Published: (2018-03-01)